USD 0.0
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.12 Million USD | 6.45% |
2022 | 1.05 Million USD | 60.25% |
2021 | 658.41 Thousand USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 531.97 Thousand USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | -100.0% |
2013 | 140 Thousand USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q3 | 1.12 Million USD | 0.0% |
2024 Q1 | 1.12 Million USD | 0.0% |
2024 Q2 | 1.12 Million USD | 0.0% |
2023 Q3 | 1.53 Million USD | 32.95% |
2023 FY | 1.12 Million USD | 6.45% |
2023 Q4 | 1.12 Million USD | -26.74% |
2023 Q1 | 1.14 Million USD | 8.18% |
2023 Q2 | 1.15 Million USD | 1.03% |
2022 Q3 | 1.06 Million USD | -8.62% |
2022 FY | 1.05 Million USD | 60.25% |
2022 Q4 | 1.05 Million USD | -1.27% |
2022 Q2 | 1.16 Million USD | 36.66% |
2022 Q1 | 855.77 Thousand USD | 29.97% |
2021 Q3 | 89.16 Thousand USD | -12.51% |
2021 Q2 | 101.9 Thousand USD | 0.0% |
2021 Q4 | 658.41 Thousand USD | 638.46% |
2021 FY | 658.41 Thousand USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 FY | - USD | -100.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q1 | - USD | -100.0% |
2016 Q2 | 501.85 Thousand USD | -0.94% |
2016 Q3 | 516.91 Thousand USD | 3.0% |
2016 Q4 | 531.97 Thousand USD | 2.91% |
2016 Q1 | 506.63 Thousand USD | 0.0% |
2016 FY | 531.97 Thousand USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q2 | - USD | -100.0% |
2014 Q1 | 140 Thousand USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | -100.0% |
2013 Q2 | 140 Thousand USD | 0.0% |
2013 Q4 | 140 Thousand USD | -15.15% |
2013 FY | 140 Thousand USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q3 | 165 Thousand USD | 17.86% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Gene Biotherapeutics, Inc. | - USD | -Infinity% |
Evolutionary Genomics, Inc. | 3.74 Million USD | 70.0% |
Innovation1 Biotech Inc. | 218.99 Thousand USD | -412.851% |
Point of Care Nano-Technology, Inc. | - USD | -Infinity% |
Vicapsys Life Sciences, Inc. | - USD | -Infinity% |